Our research comprises a broad range of areas from which postdoctoral scholars and their mentors create research projects in a rich and unique drug discovery environment, including access to sophisticated research tools.

Projects are often interdisciplinary in nature, combining biology and chemistry and/or computational approaches, or bridging different disease areas.

With a "brain in a dish," researchers take on a host of neurological disorders

A key guiding principle is that our postdocs present their work at major research conferences and publish their results in leading peer-reviewed journals. See featured publications with our postdocs as lead authors.

Reverse translation of adverse event reports paves the way for de-risking preclinical off-targets

Indoleacrylic acid produced by commensal Peptostreptococcus species suppresses inflammation

Learn more about our Postdoc Program alumni who have gone on to careers as principal investigators at academic institutions.

Andreas Bender, Ph.D.

Andreas Bender is the quintessential hybrid scientist. He knows how industry research works from the inside, having spent two years at NIBR as a postdoctoral fellow, and he has since built his career in an academic setting.

Sereina Riniker, Ph.D.

The Eidgenössische Technische Hochschule Zurich is one of the world’s leading academic research institutions and the home to nearly 20 000 students and more than 500 professors. In 2014, Sereina Riniker joined their ranks as their youngest professor.

Boxun Lu, Ph.D.

As a postdoc at NIBR from 2010 to 2012, Boxun Lu worked on neurodegenerative disorders, including Huntington’s disease. Since then, he has continued this research in his lab at Fudan University in Shanghai.